SFA
TLSIW icon

Sequoia Financial Advisors’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Sequoia Financial Advisors’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-62,187
Closed -$103K – 1370
2024
Q2 		$103K Hold
62,187
– – ﹤0.01% 1159
2024
Q1 		$62.2K Hold
62,187
– – ﹤0.01% 1133
2023
Q4 		$74K Hold
62,187
– – ﹤0.01% 1169
2023
Q3 		$23.6K Hold
62,187
– – ﹤0.01% 957
2023
Q2 		$3K Buy
+62,187
New +$4.22K ﹤0.01% 968

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sequoia Financial Advisors's TLSIW Position: Q3 2024 in Review

Sequoia Financial Advisors sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 62,187 shares — an estimated $103K sold.

Sequoia Financial Advisors first reported a position in TLSIW in Q2 2023 and held it in 5 quarters. The position peaked at $103K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • Sequoia Financial Advisors reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • Sequoia Financial Advisors sold 62,187 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $103K.
  • Sequoia Financial Advisors first reported a position in TriSalus Life Sciences Warrant in Q2 2023 and held it in 5 quarters.
  • Sequoia Financial Advisors's TriSalus Life Sciences Warrant position peaked at $103K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on Sequoia Financial Advisors's 13F filing for Q3 2024, filed 21 Oct 2024.